Article Information
History
- July 15, 2021.
Article Versions
- Version 1 (February 23, 2021 - 11:15).
- Version 2 (February 28, 2021 - 01:33).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hui Shi1,2,
- Alex A. Gandhi1,
- Stephanie A. Smith3,
- Qiuyu Wang4,
- Diane Chiang1,
- Srilakshmi Yalavarthi1,
- Ramadan A. Ali1,
- Chao Liu1,
- Gautam Sule1,
- Pei-Suen Tsou1,
- Yu Zuo1,
- Yogendra Kanthi5,6,
- Evan A. Farkash7,
- Jiandie D. Lin4,
- James H. Morrissey3 and
- Jason S. Knight1,*
- 1Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
- 2Division of Rheumatology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
- 3Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan, USA, 20892
- 4Life Sciences Institute and Department of Cell & Developmental Biology, University of Michigan Medical Center, Ann Arbor, MI, USA
- 5Division of Intramural Research National Heart, Lung and Blood Institute Bethesda, Maryland, USA
- 6Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
- 7Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA
- ↵*Correspondence
Jason S. Knight, MD, PhD, jsknight{at}umich.edu
Posted July 15, 2021.
Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide
